References
Postner MR, Mayer RJ: The use of serologic tumor markers in gastrointestinal malignancies. Hemarol Oncol Clin North Am 8:533–553, 1994
Bast, RC Jr, Ravdin P, Hayes, DF, et al.: Update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 15:1865–1878, 2001
Safadi R, Ligumsky M, Goldin E, Ilan Y, Haviv YS, Nusair S: Increased serum CA 19-9 antibodies in Sjogren’s syndrome. Postgrad Med J 74(875):543–544, 1998
Schmid KW, Ofner C, Ramsauer T, Hittmair A, Totsch M, Ladurner D, Bocker W: CA 19-9 expression in subacute (de Quervain’s) thyroiditis: An immunohistochemical study. Mod Pathol 5(3):268–272, 1992
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parra, J.L., Kaplan, S. & Barkin, J.S. Elevated CA 19-9 Caused by Hashimoto’s Thyroiditis: Review of the Benign Causes of Increased CA 19-9 Level. Dig Dis Sci 50, 694–695 (2005). https://doi.org/10.1007/s10620-005-2559-z
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-2559-z